Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Amitriptyline hydrochloride by AlgoTherapeutix for Erythromelalgia: Likelihood of Approval
Amitriptyline hydrochloride is under clinical development by AlgoTherapeutix and currently in Phase II for Erythromelalgia. According to GlobalData, Phase II...
Data Insights
Amitriptyline hydrochloride by AlgoTherapeutix for Chemotherapy Induced Peripheral Neuropathy: Likelihood of Approval
Amitriptyline hydrochloride is under clinical development by AlgoTherapeutix and currently in Phase II for Chemotherapy Induced Peripheral Neuropathy. According to...